1. Home
  2. FCO vs NEPH Comparison

FCO vs NEPH Comparison

Compare FCO & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo abrdn Global Income Fund Inc.

FCO

abrdn Global Income Fund Inc.

HOLD

Current Price

$2.97

Market Cap

39.4M

Sector

Finance

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$5.65

Market Cap

46.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCO
NEPH
Founded
1991
1997
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.4M
46.8M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
FCO
NEPH
Price
$2.97
$5.65
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
100.1K
75.4K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
14.96%
N/A
EPS Growth
N/A
N/A
EPS
0.43
0.14
Revenue
N/A
$17,930,000.00
Revenue This Year
N/A
$24.38
Revenue Next Year
N/A
$10.16
P/E Ratio
$12.30
$42.06
Revenue Growth
N/A
32.36
52 Week Low
$4.73
$1.39
52 Week High
$6.63
$6.42

Technical Indicators

Market Signals
Indicator
FCO
NEPH
Relative Strength Index (RSI) 45.52 56.33
Support Level $2.89 $5.06
Resistance Level $3.02 $5.63
Average True Range (ATR) 0.07 0.63
MACD 0.02 0.07
Stochastic Oscillator 60.14 60.55

Price Performance

Historical Comparison
FCO
NEPH

About FCO abrdn Global Income Fund Inc.

abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: